MedPath
NMPA Approval

Rifaximin Soft Capsules

国药准字H20050128

April 15, 2020

Drug Information

利福昔明软胶囊

胶囊剂

0.1g

化学药品

April 15, 2020

Company Information

Applicant Company

Manufacturing Company

宁波经济开发区C1区(小港)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福昔明软胶囊 - NMPA 批准文号 | MedPath